Immunitas Therapeutics nets $39 mln Series A

Cambridge, Massachusetts-based Immunitas Therapeutics, a single cell genomics-based drug discovery company founded by Longwood Fund, has secured $39 million in Series A financing. Leaps by Bayer and Novartis Venture Fund led the round.